Elective Percutaneous Coronary Intervention in Ambulatory Surgery Centers

被引:6
|
作者
Li, Kevin [1 ]
Kalwani, Neil M. [2 ]
Heidenreich, Paul A. [2 ]
Fearon, William F. [2 ]
机构
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Stanford Cardiovasc Inst, Div Cardiovasc Med, 300 Pasteur Dr,H2103, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
ischemic heart disease; outcomes; PCI; percutaneous coronary intervention; health services research; SAME-DAY DISCHARGE; TEMPORAL TRENDS; ANGIOGRAPHY; MORTALITY; OUTCOMES; ACCESS; IMPACT; RISK; SITE;
D O I
10.1016/j.jcin.2020.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to explore characteristics and outcomes of patients undergoing elective percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs). BACKGROUND Little is known about patients who underwent ASC PCI before Medicare reimbursement was instituted in 2020. METHODS Using commercial insurance claims from MarketScan, adults who underwent hospital outpatient department (HOPD) or ASC PCI for stable ischemic heart disease from 2007 to 2016 were studied. Propensity score analysis was used to measure the association between treatment setting and the primary composite outcome of 30-day myocardial infarction, bleeding complications, and hospital admission. RESULTS The unmatched sample consisted of 95,492 HOPD and 849 ASC PCIs. Patients who underwent ASC PCI were more likely to be younger than 65 years, to live in the southern United States, and to have managed or consumer-driven health insurance. ASC PCI was also associated with decreased fractional flow reserve utilization (odds ratio [OR]: 0.31; 95% confidence interval [CI]: 0.20 to 0.48; p < 0.001). In unmatched, multivariate analysis, ASC PCI was associated with increased odds of the primary outcome (OR: 1.25; 95% CI: 1.01 to 1.56; p = 0.039) and bleeding complications (OR: 1.80; 95% CI: 1.11 to 2.90; p = 0.016). In propensity-matched analysis, ASC PCI was not associated with the primary outcome (OR: 1.23; 95% CI: 0.94 to 1.60; p = 0.124) but was significantly associated with increased bleeding complications (OR: 2.49; 95% CI: 1.25 to 4.95; p = 0.009). CONCLUSIONS Commercially insured patients undergoing ASC PCI were less likely to undergo fractional flow reserve testing and had higher odds of bleeding complications than HOPD-treated patients. Further study is warranted as Medicare ASC PCI volume increases. (J Am Coll Cardiol Intv 2021;14:292-300) Published by Elsevier on behalf of the American College of Cardiology Foundation
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [21] The role of elective coronary surgery early after acute myocardial infarction in the era of primary percutaneous coronary intervention
    Zielinska, Marzenna
    Plesiewicz, Izabela
    Walczak, Andrzej
    Jaszewski, Ryszard
    Goch, Jan Henryk
    ACTA CARDIOLOGICA, 2007, 62 (02) : 183 - 188
  • [22] Neurological Complications Following Elective Coronary Angiography and/or Percutaneous Coronary Intervention
    Matejka, Jan
    Lazarak, Tomas
    Novotny, Vojtech
    Rozsival, Vladimir
    Varvarovsky, Ivo
    Vojtisek, Petr
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B155 - B155
  • [23] The effect of elective percutaneous coronary intervention on coronary haemodynamics and microvascular function
    Hadjiloizou, N.
    Davies, J.
    Baksi, A. J.
    Malik, I.
    Foale, R.
    Parker, K.
    Hughes, A.
    Francis, D.
    Mayet, J.
    EUROPEAN HEART JOURNAL, 2008, 29 : 82 - 82
  • [24] Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention
    Mangiacapra, Fabio
    Colaiori, Iginio
    Di Gioia, Giuseppe
    Pellicano, Mariano
    Heyse, Alex
    Paolucci, Luca
    Peace, Aaron
    Bartunek, Jozef
    de Bruyne, Bernard
    Barbato, Emanuele
    HEART, 2024, 110 (02) : 115 - 121
  • [25] Economic and clinical analysis of elective percutaneous coronary intervention without on-site cardiac surgery
    Long, KH
    Ting, HH
    Mc Murtry, EK
    Terry, AS
    Tiggelaar, TH
    Lennon, RJ
    Garrett, KN
    Singh, M
    Rihal, CS
    Wood, DL
    Holmes, DR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 44A - 44A
  • [26] The predicament of offering elective percutaneous coronary intervention at sites without on-site cardiac surgery
    Singh, Mandeep
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 810 - 811
  • [27] Elective percutaneous coronary intervention without on-site cardiac surgery - Clinical and economic implications
    Long, KH
    McMurtry, EK
    Lennon, RJ
    Chapman, AC
    Singh, M
    Rihal, CS
    Wood, DL
    Holmes, DR
    Ting, HH
    MEDICAL CARE, 2006, 44 (05) : 406 - 413
  • [28] Economic and clinical analysis of elective percutaneous coronary intervention without on-site cardiac surgery
    Ting, HH
    Long, KH
    McMurtry, EK
    Terry, AS
    Tiggelaar, TH
    Lennon, RJ
    Garratt, KN
    Singh, M
    Rihal, CS
    Wood, DL
    Holmes, DR
    CIRCULATION, 2003, 107 (19) : E147 - E147
  • [29] Evaluating the risk of coronary surgery and percutaneous coronary intervention
    Weintraub, WS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) : 669 - 671
  • [30] Clopidogrel: still king of the ring for elective percutaneous coronary intervention!
    Montalescot, Gilles
    Ferrante, Arnaud
    EUROINTERVENTION, 2023, 18 (15) : 1213 - 1214